ALV.NYSEAutoliv INC

Form 4: Autoliv CTO Accrues RSUs from Dividend Equivalents

Sentiment:

Insider Transaction Report


Autoliv's EVP & Chief Technology Officer, Fabien Dumont, reported the acquisition of additional Restricted Stock Units through dividend equivalent rights.

Summary

  • Fabien Dumont, Autoliv Inc.'s EVP & Chief Technology Officer, reported an acquisition of derivative securities on December 10, 2025.
  • The acquisition consisted of additional Restricted Stock Units (RSUs) accrued as dividend equivalent rights.
  • These dividend equivalent rights resulted in the acquisition of 5.1806 Performance-Based RSUs (2023 Grant), 1.4761 Performance-Based RSUs (2024 Grant), 1.7219 RSUs, 1.3543 RSUs, and 3.7567 RSUs.
  • Following these transactions, Mr. Dumont beneficially owns 718.9669 Performance-Based RSUs (2023 Grant), 204.8609 Performance-Based RSUs (2024 Grant), 238.9641 RSUs (vesting 02/15/2026), 187.9458 RSUs (vesting 02/20/2027), and 521.3638 RSUs (vesting 02/20/2028).
  • The Performance-Based RSUs vest after the completion of their respective third one-year performance periods ending December 31, 2025, and December 31, 2026, subject to certification of performance objectives.

Sentiment

Score: 5

Explanation: The filing reports a routine, non-discretionary transaction related to executive compensation (accrual of dividend equivalent rights on existing RSUs). It does not indicate any new strategic developments, financial performance changes, or significant shifts in company outlook, thus maintaining a neutral sentiment.

Positives

  • The accrual of additional Restricted Stock Units (RSUs) through dividend equivalent rights indicates ongoing equity participation and alignment of executive interests with shareholder returns.
  • The increase in beneficially owned RSUs strengthens the executive's long-term incentive to contribute to the company's performance.

Future Outlook

The future outlook includes the vesting of various tranches of Restricted Stock Units (RSUs) and Performance-Based RSUs on specific dates, contingent on performance objectives for the latter. The Performance-Based RSUs from the 2023 grant are expected to vest after December 31, 2025, and the 2024 grant after December 31, 2026, subject to committee certification. Other RSUs have fixed vesting dates in February 2026, 2027, and 2028.

Industry Context

The accrual of dividend equivalent rights in the form of additional Restricted Stock Units is a common practice in executive compensation plans across various industries. It serves to maintain the value of equity awards by accounting for dividends paid on underlying common stock, aligning executive incentives with long-term shareholder value creation.

Comparison to Industry Standards

  • The practice of accruing dividend equivalent rights on Restricted Stock Units (RSUs) is a standard feature in many corporate executive compensation programs, comparable to practices at peer companies in the automotive safety systems and broader manufacturing sectors.
  • This mechanism ensures that RSU holders receive the economic benefit of dividends, similar to common shareholders, thereby maintaining the intended value of their long-term incentive awards.

Stakeholder Impact

  • Shareholders: The transaction is a routine part of executive compensation, aligning management's long-term interests with shareholder value through equity ownership. It does not directly impact current share price or dividend policy.
  • Employees: No direct impact on general employees is indicated by this specific filing.
  • Management: The executive's equity stake increases, reinforcing their commitment to the company's long-term performance.

Next Steps

  • The Leadership Development and Compensation Committee will certify the level of achievement of applicable performance objectives for the 2023 Performance-Based RSUs after December 31, 2025.
  • The Leadership Development and Compensation Committee will certify the level of achievement of applicable performance objectives for the 2024 Performance-Based RSUs after December 31, 2026.
  • Various tranches of Restricted Stock Units are scheduled to vest on February 15, 2026, February 20, 2027, and February 20, 2028.

Key Dates

DateDescription
12/10/2025Transaction date for the acquisition of dividend equivalent RSUs.
12/11/2025Date the Form 4 was signed by Brian Kelly as Power of Attorney for Fabien Dumont.
12/31/2025End of the third one-year performance period for the 2023 Performance-Based RSUs, after which they vest upon certification.
02/15/2026Vesting date for a tranche of Restricted Stock Units.
12/31/2026End of the third one-year performance period for the 2024 Performance-Based RSUs, after which they vest upon certification.
02/20/2027Vesting date for a tranche of Restricted Stock Units.
02/20/2028Vesting date for a tranche of Restricted Stock Units.

Recommendation

hold

This Form 4 reports a routine, non-discretionary acquisition of additional Restricted Stock Units (RSUs) by Autoliv's EVP & Chief Technology Officer, Fabien Dumont, through dividend equivalent rights. This is a standard component of executive compensation and does not indicate any new strategic developments or significant changes in the company's financial health. Therefore, it does not warrant a change in investment recommendation based solely on this filing.

Keywords

Autoliv, ALV, SEC Form 4, Insider Transaction, Restricted Stock Units, RSU, Executive Compensation, Dividend Equivalent Rights, Fabien Dumont

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.